mAbDx and Oregon State University have agreed to jointly develop rapid tests and reagents for diagnosis of vibriosis in marine shellfish hatcheries. Vibrio tubiashii (Vt) is a bacterial shellfish pathogen that causes serious disruptions in hatchery production and is currently difficult to detect and manage. The novel diagnostic test is …
read moremAbDx Chief Scientific Officer Michael Marusich, Ph.D., presents recent research to identify and characterize new mtDAMPs that drive the Systemic Inflammatory Response Syndrome (SIRS) after trauma
mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presented a research report titled “Defining the contribution of mitochondrial peptides to SIRS after tissue injury” at the 2013 Mérieux Research Grants Meeting, held in Annecy, France, Sept 11-13. The work is a collaborative research project by Michael Marusich, Ph.D., mAbDx …
read moremAbDx moves into a new custom-built biotechnology laboratory in the recently completed Lewis Integrative Sciences Building on the University of Oregon campus
mAbDx has relocated into private laboratory and office space in the newly completed Lewis Integrative Sciences Building on the campus of the University of Oregon. The laboratory is designed for biotechnology research, in particular the development, characterization and validation of novel monoclonal antibodies and immunoassays.
read moreMichael Marusich, Ph.D., mAbDx, and Carl Hauser, M.D., Harvard, awarded collaborative Mérieux Research Grant to identify and characterize new mtDAMPs that drive systemic inflammation after trauma
mAbDx is pleased to announce that Michael Marusich, Ph.D., mAbDx, and Carl Hauser, M.D., Harvard, have been awarded a collaborative Mérieux Research Grant to identify new mitochondrial Damage Associated Molecular Patterns (mtDAMPs) that drive Systemic Inflammatory Response Syndrome (SIRS) after trauma. Post-trauma SIRS is a common, potentially life-threatening …
read moremAbDx awarded University of Oregon Venture Launch Grant to develop non-invasive diagnostic tests for head and neck cancer
mAbDx is pleased to announce it has been awarded an Oregon Venture Launch Grant to develop non-invasive (saliva-based) diagnostic tests for head and neck cancer. The award will support growth of mAbDx's pipeline of novel biomarkers and immunodiagnostics for cancer and inflammatory diseases.
Head and Neck Squamous Cell Carcinoma (HNSCC …
read more